Leading Dutch scientists share their views on prevention and treatment of cancer

On Nano World Cancer Day 2016 leading Dutch scientists shared their views on how to prevent and treat cancer with nanomedicine. On 2 February a mix of scientists, engineers, policymakers and patient representatives were present at the Mini conference on nanomedicine and cancer in Utrecht. They enjoyed six clear, concise and interesting lectures about the application of nanomedicine in the prevention and treatment of cancer. A short report of the Mini conference nanomedicine and cancer is now available.

Possibilities, chemotherapeutics and chemotherapy

Some quotes of leading Dutch scientists present at the mini conference Nano World Cancer Day 2016:

“There are a lot of possibilities, but we have to look for the right particles.”
– Bob Pinedo (MESA+, University of Twente; Imaging Center, VUmc Amsterdam)

Bob Pinedo Mini conference nanomedicine and cancer February 2016

Award winning medical oncologist Prof. Dr. Bob Pinedo elaborated on the different nanoparticles that are used nowadays in the field of oncology. There are already a lot of possibilities, but the future of nanomedicine in cancer treatment will rely on application of the correct and most effective particle for treatment.

“Often chemotherapeutics end up in other organs and not in the tumor. Nanomedicine will aid image-guided drug delivery.”
– Twan Lammers (RTWH Aachen)

By delivering drugs more specifically to the site of the tumor, and by preventing them from accumulating in potentially endangered healthy tissues, nanomedicines are able to improve the balance between the efficacy and the toxicity of chemotherapy.

“The dose for chemotherapy is often suboptimal because of side effects.”
– Roel Deckers (UMC Utrecht)

In recent years a technique and protocol has been developed for image guided local drug delivery for treatment of breast cancer. Compared to current available methods this technique and protocol is predicted to perform better and more specific and patients will experience less side effects.

More information

Short report Mini conference nanomedicine and cancer